Swedish Orphan Biovitrum AB (publ)
556038-9321ActiveGlobal biopharma unlocking breakthrough therapies for rare diseases.
Biopharmaceutical Companysobi.com
Yleiskatsaus
- 200–499
- Työntekijät
- 5–10mrd SEK
- Liikevaihto
- 1972
- Perustettu
Avainpäättäjät
Iris Loew-Friedrich
Board member
@sobi.com
Bo Jesper Hansen
Chairman of the Board
@sobi.com
Zlatko Rihter
Board member
@sobi.com
Duane H. Barnes
Head of North America
@sobi.com
+37 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Sobi, or Swedish Orphan Biovitrum AB, is a global biopharmaceutical company dedicated to transforming the everyday lives of people living with rare diseases. The organization focuses intensely on unlocking the potential of breakthrough innovations where the unmet patient need is high. Their core the...
VIFOR PHARMA NORDISKA AB